CA
GWPH

Calton & Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Calton & Associates’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-94
Closed -$13K – 1399
2017
Q4 		$13K Buy
+94
New +$11K ﹤0.01% 1006

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Calton & Associates's GWPH Position: Q1 2018 in Review

Calton & Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2018, closing a stake of 94 shares — an estimated $13K sold.

Calton & Associates first reported a position in GWPH in Q4 2017 and held it in 1 quarter. The position peaked at $13K in Q4 2017. 191 funds tracked by Wall St. Rank hold GWPH as of Q1 2018.

  • Calton & Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 94 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2018, an estimated $13K.
  • Calton & Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $13K in Q4 2017.
  • 191 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.